Literature DB >> 17341501

A novel echocardiographic predictor of in-hospital mortality and mid-term haemodynamic improvement after pulmonary endarterectomy for chronic thrombo-embolic pulmonary hypertension.

Maxim Hardziyenka1, Herre J Reesink, Berto J Bouma, H A C M Rianne de Bruin-Bon, Maria E Campian, Michael W T Tanck, Renée B A van den Brink, Jaap J Kloek, Hanno L Tan, Paul Bresser.   

Abstract

AIMS: To study whether pre-operative assessment, using echocardiography, of the timing of a particular feature in the pulmonary flow (pulmonary flow systolic notch) may predict in-hospital mortality and mid-term haemodynamic improvement after pulmonary endarterectomy (PEA) for chronic thrombo-embolic pulmonary hypertension (CTEPH). METHODS AND
RESULTS: Fifty-eight of 61 consecutive CTEPH patients (aged 53 +/- 14 years; 36 women) who underwent PEA between June 2002 and June 2005 were studied. Clinical, haemodynamic, and echocardiographic variables were assessed pre-operatively and at 3 months post-PEA. Timing of the notch was expressed as notch ratio (NR). Pre-operatively, seven patients had no notch, 33 had NR < 1.0, and 18 had NR > 1.0. NR was associated with in-hospital mortality (P < 0.01). Moreover, multivariable analysis revealed that among pre-operative variables, NR was an independent predictor of residual-increased pulmonary artery systolic pressure (>40 mmHg) at 3 months post-PEA (P = 0.01). Receiver operator characteristic analysis established NR = 1.0 as optimal cutoff to distinguish patients at risk of such unfavourable outcomes, with NR > 1.0 conferring higher risk.
CONCLUSION: NR is related with in-hospital mortality and residual pulmonary hypertension after PEA. NR > 1.0 is associated with a higher risk of such unfavourable outcomes. NR may be considered a determinant of eligibility for PEA.

Entities:  

Mesh:

Year:  2007        PMID: 17341501     DOI: 10.1093/eurheartj/ehl534

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  13 in total

1.  Circulating collagen biomarkers as indicators of disease severity in pulmonary arterial hypertension.

Authors:  Zeenat Safdar; Emilio Tamez; Wenyaw Chan; Basant Arya; Yimin Ge; Anita Deswal; Biykem Bozkurt; Adaani Frost; Mark Entman
Journal:  JACC Heart Fail       Date:  2014-07-09       Impact factor: 12.035

2.  Prediction of hemodynamic improvement after pulmonary endarterectomy in chronic thromboembolic pulmonary hypertension using non-invasive imaging.

Authors:  Bastiaan E Schölzel; Martijn C Post; Alexander van de Bruaene; Steven Dymarkowski; Wim Wuyts; Bart Meyns; Werner Budts; Marion Delcroix
Journal:  Int J Cardiovasc Imaging       Date:  2014-08-22       Impact factor: 2.357

3.  Diagnostic evaluation and management of chronic thromboembolic pulmonary hypertension: a clinical practice guideline.

Authors:  Sanjay Mehta; Doug Helmersen; Steeve Provencher; Naushad Hirani; Fraser D Rubens; Marc De Perrot; Mark Blostein; Kim Boutet; George Chandy; Carole Dennie; John Granton; Paul Hernandez; Andrew M Hirsch; Karen Laframboise; Robert D Levy; Dale Lien; Simon Martel; Gerard Shoemaker; John Swiston; Justin Weinkauf
Journal:  Can Respir J       Date:  2010 Nov-Dec       Impact factor: 2.409

4.  Are pulmonary artery pulsatility indexes able to differentiate chronic pulmonary thromboembolism from pulmonary arterial hypertension? An echocardiographic and catheterization study.

Authors:  Tomas Palecek; Pavel Jansa; David Ambroz; Zuzana Hlubocka; Jan Horak; Marcela Skvarilova; Michael Aschermann; Ales Linhart
Journal:  Heart Vessels       Date:  2010-10-16       Impact factor: 2.037

5.  Pulmonary vascular remodeling before and after pulmonary endarterectomy in patients with chronic thromboembolic pulmonary hypertension: a cardiac magnetic resonance study.

Authors:  Andreas Rolf; Johannes Rixe; Won K Kim; Stefan Guth; Nils Körlings; Helge Möllmann; Holger M Nef; Christoph Liebetrau; Gabriele Krombach; Thorsten Kramm; Eckhard Mayer; Christian W Hamm
Journal:  Int J Cardiovasc Imaging       Date:  2014-12-18       Impact factor: 2.357

6.  Mechanics and Function of the Pulmonary Vasculature: Implications for Pulmonary Vascular Disease and Right Ventricular Function.

Authors:  Steven Lammers; Devon Scott; Kendall Hunter; Wei Tan; Robin Shandas; Kurt R Stenmark
Journal:  Compr Physiol       Date:  2012-01-01       Impact factor: 9.090

7.  The actuarial survival analysis of the surgical and non-surgical therapy regimen for chronic thromboembolic pulmonary hypertension.

Authors:  Hui-Li Gan; Jian-Qun Zhang; Ping Bo; Qi-Wen Zhou; Sheng-Xun Wang
Journal:  J Thromb Thrombolysis       Date:  2009-04-11       Impact factor: 2.300

8.  Bosentan treatment is associated with improvement of right ventricular function and remodeling in chronic thromboembolic pulmonary hypertension.

Authors:  Sulaiman Surie; Herre J Reesink; J Tim Marcus; Mart N van der Plas; Jaap J Kloek; Anton Vonk-Noordegraaf; Paul Bresser
Journal:  Clin Cardiol       Date:  2013-08-27       Impact factor: 2.882

9.  Pulmonary flow profile and distensibility following acute pulmonary embolism.

Authors:  Frederikus A Klok; Soha Romeih; Jos J M Westenberg; Lucia J M Kroft; Menno V Huisman; Albert de Roos
Journal:  J Cardiovasc Magn Reson       Date:  2011-02-18       Impact factor: 5.364

10.  Diagnosis and assessment of pulmonary vascular disease by Doppler echocardiography.

Authors:  Justin D Roberts; Paul R Forfia
Journal:  Pulm Circ       Date:  2011 Apr-Jun       Impact factor: 3.017

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.